AI assistant
Sending…
BECTON DICKINSON & CO — Director's Dealing 2019
Nov 27, 2019
30003_dirs_2019-11-27_a037b146-7725-494f-a0b0-32eef4de2457.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BECTON DICKINSON & CO (BDX)
CIK: 0000010795
Period of Report: 2019-11-26
Reporting Person: Kaltenbach Patrick (EVP & Pres Life Sciences)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-11-26 | Common Stock | F | 308 | — | Disposed | 15622 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-11-26 | Stock Appreciation Rights | $255.22 | A | 18119 | Acquired | 2029-11-26 | Common Stock (18119) | Direct |
Footnotes
F1: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I.
F2: The stock appreciation rights vest in four annual installments beginning November 26, 2020.
More from BECTON DICKINSON & CO
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7